Amoebiasis: clinical trials of dehydroemetine late-release tablets (Ro 1-9334-20) compared with parenteral dehydroemetine and niridazole.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000562:Amebiasis / Q000188:drug therapy*; D000871:Anthelmintics / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004640:Emetine / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged
D000871:Anthelmintics; D003692:Delayed-Action Preparations; D004640:Emetine